Table 1. The characteristics of patients.
Case | Gender | Age | EBV-Infected cells | Clinical findings | Clonality of the EBV-infected cells | EBV DNA load (copies/μg DNA) of the whole blood | EBV DNA load (copies/μg DNA) of the EBV-infected cells fraction in the PBMCs | The rate of the EBV-infected cell fractions in the PBMCs |
---|---|---|---|---|---|---|---|---|
1 | F | 25 | CD4 | Fever, liver dysfunction, lymphadenopathy | Monoclonal | 7.0 × 104 | 2.2 × 105 (CD4) | 71.2% |
2 | M | 45 | CD4 | Fever, sMBA | Monoclonal | 1.7 × 103 | 1.7 × 104 (CD4) | NE |
3 | M | 34 | CD4 | Fever | Monoclonal | 5.7 × 104 | 4.9 × 105 (CD4) | 54.3% |
4 | M | 20 | CD4 | Fever, liver dysfunction, lymphadenopathy | Monoclonal | 2.0 × 105 | 1.5 × 105 (CD4) | 60.5% |
5 | F | 38 | CD8 | Fever, liver dysfunction, lymphadenopathy | Monoclonal | 1.4 × 105 | 3.9 × 105 (CD8) | 76.5% |
6 | F | 21 | CD8 | Fever, liver dysfunction | Monoclonal | 4.7 × 104 | 1.7 × 104 (CD8) | 50.0% |
7 | F | 64 | CD8 | Fever, liver dysfunction, lymphadenopathy | Monoclonal | 2.6 × 105 | 1.2 × 106 (CD8) | 51.0% |
8 | M | 28 | CD8 | Fever, liver dysfunction, lymphadenopathy, neuritis | Monoclonal | 1.9 × 103 | 4.1 × 105 (CD8) | NE |
9 | F | 18 | CD56 | sMBA | Monoclonal | 5.2 × 104 | 1.6 × 106 (CD56) | 3.8% |
10 | F | 48 | CD56 | Fever, sMBA, HLH | Monoclonal | 8.6 × 104 | 1.6 × 105 (CD56) | 10.0% |
11 | F | 23 | CD56 | sMBA | Monoclonal | 5.1 × 104 | 4.6 × 105 (CD56) | 17.9% |
12 | M | 37 | CD4, CD56 | Fever, lymphadenopathy | Monoclonal | 1.9 × 105 | 1.9 × 105 (CD4),1.1 × 106 (CD56) | 30.0% (CD4), 0.2% (CD56) |
13 | F | 18 | CD4, CD56 | Fever, polyneuropathy, | Monoclonal | 6.0 × 104 | 1.7 × 105 (CD4), 7.1 × 106 CD56) | 35.2% (CD4), 2.3% (CD56) |
14 | F | 22 | CD4, CD8 | Fever, HV | Monoclonal | 7.2 × 104 | 1.8 × 104 (CD4), 1.4 × 105 (CD8) | 41.2% (CD4), 51.7% (CD8) |
F, female; M, male; NE, not examined
EBV; Epstein-Barr virus, PBMCs; peripheral blood mononuclear cells, F; female, M; male, sMBA; severe mosquito bite allergy, NE; not examined, HLH; Hemophagocytic lymphohistiocytosis, HV; hydroa vacciniforme-like eruption